Document and Entity Information |
Dec. 14, 2025 |
|---|---|
| Document And Entity Information [Line Items] | |
| Document Type | 8-K/A |
| Document Period End Date | Dec. 14, 2025 |
| Entity Registrant Name | Silence Therapeutics plc |
| Entity Incorporation State Country Code | X0 |
| Entity File Number | 001-39487 |
| Entity Tax Identification Number | 00-0000000 |
| Entity Address Address Line 1 | 12 Hammersmith Grove |
| Entity Address City Or Town | London |
| Entity Address Country | GB |
| Entity Address Postal Zip Code | W6 7AP |
| Country Region | 44 |
| City Area Code | 20 |
| Local Phone Number | 3457 6900 |
| Written Communications | false |
| Soliciting Material | false |
| Pre Commencement Tender Offer | false |
| Pre Commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | false |
| Amendment Flag | true |
| Amendment Description | Silence Therapeutics plc (the “Company”) is filing this Amendment No. 1 to its Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on December 15, 2025 (the “Original Report”) solely for the purpose of disclosing (1) the material terms of the compensation arrangement that the Company entered into with Iain Ross, the Company’s interim principal executive officer on December 18, 2025, and (2) the Board committee appointments of James Ede-Golightly, which were not contemplated at the time of the filing of the Original Report. Other than as set forth in this Explanatory Note, this Amendment No. 1 does not amend any other disclosures in the Original Report. |
| Entity Central Index Key | 0001479615 |
| ADR [Member] | |
| Document And Entity Information [Line Items] | |
| Security 12b Title | American Depositary Shares, each representing 3 ordinary shares, nominal value £0.05 per share |
| Trading Symbol | SLN |
| Security Exchange Name | NASDAQ |
| Common Stock [Member] | |
| Document And Entity Information [Line Items] | |
| Security 12b Title | Ordinary share, nominal value £0.05 per share |
| Security Exchange Name | NASDAQ |
| No Trading Symbol Flag | true |